Trauma, Orthopedic, Plastic and Hand Surgery, University Hospital of Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany.
Eur J Trauma Emerg Surg. 2023 Feb;49(1):173-179. doi: 10.1007/s00068-022-02090-y. Epub 2022 Sep 12.
Blood loss after proximal femoral fractures is an important risk factor for postoperative outcome and recovery. The purpose of our study was to investigate the total blood loss depending on fracture type and additional risks, such as anticoagulant use, to be able to recognize vulnerable patients depending on planned surgery and underlying comorbidities.
A retrospective single center study including 1478 patients treated operatively for a proximal femoral fracture between January 2016 and June 2020 at a level I trauma center. Patient data, surgical procedure, time to surgery, complications and mortality were assessed. Lab data including hemoglobin and transfusion rates were collected. The Mercuriali formula was implemented to calculate total blood loss. Linear regression was performed to identify influencing factors.
One thousand four hundred seventy-eight mainly female patients were included in the study (mean age: 79.8 years) comprising 667 femoral neck fractures, 704 pertrochanteric- and 107 subtrochanteric fractures. Nearly 50% of the cohort were on anticoagulants or anti- platelet therapy. At time of admission average hemoglobin was 12.1 g/l. Linear regression proved fracture morphology, age, BMI, in-house mortality and anticoagulant use to have crucial influence on postoperative blood loss. Femoral neck fractures had a blood loss of 1227.5 ml (SD 740.4 ml), pertrochanteric fractures lost 1,474.2 ml (SD 830 ml) and subtrochanteric femoral fractures lost 1902.2 ml (SD 1,058 ml).
Hidden blood loss is underestimated. Anticoagulant use, fracture type, gender and BMI influence the total blood loss. Hemoglobin levels should be monitored closely. Within 48 h there was no increased mortality, so adequate time should be given to reduce anticoagulant levels and safely perform surgery.
股骨近端骨折后失血是术后结果和恢复的一个重要危险因素。我们的研究目的是调查根据骨折类型和抗凝剂使用等额外风险的总失血量,以便能够根据计划手术和潜在合并症识别易受影响的患者。
这是一项回顾性单中心研究,纳入了 2016 年 1 月至 2020 年 6 月期间在一级创伤中心接受手术治疗的 1478 例股骨近端骨折患者。评估了患者数据、手术程序、手术时间、并发症和死亡率。收集实验室数据,包括血红蛋白和输血率。采用 Mercuriali 公式计算总失血量。进行线性回归以确定影响因素。
本研究共纳入 1478 例主要为女性患者(平均年龄:79.8 岁),其中股骨颈骨折 667 例,股骨转子间骨折 704 例,股骨转子下骨折 107 例。近 50%的患者正在接受抗凝或抗血小板治疗。入院时平均血红蛋白为 12.1g/L。线性回归证明骨折形态、年龄、BMI、院内死亡率和抗凝剂使用对术后失血有重要影响。股骨颈骨折失血 1227.5ml(SD 740.4ml),股骨转子间骨折失血 1474.2ml(SD 830ml),股骨转子下骨折失血 1902.2ml(SD 1058ml)。
隐性失血被低估了。抗凝剂使用、骨折类型、性别和 BMI 影响总失血量。应密切监测血红蛋白水平。在 48 小时内没有增加死亡率,因此应该有足够的时间来降低抗凝剂水平并安全地进行手术。